These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32767480)
1. Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect. Correa-Vela M; Lupo V; Montpeyó M; Sancho P; Marcé-Grau A; Hernández-Vara J; Darling A; Jenkins A; Fernández-Rodríguez S; Tello C; Ramírez-Jiménez L; Pérez B; Sánchez-Montáñez Á; Macaya A; Sobrido MJ; Martinez-Vicente M; Pérez-Dueñas B; Espinós C Ann Clin Transl Neurol; 2020 Aug; 7(8):1436-1442. PubMed ID: 32767480 [TBL] [Abstract][Full Text] [Related]
2. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice. Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298 [TBL] [Abstract][Full Text] [Related]
3. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex. Wang Q; Crnković V; Preisinger C; Stegmüller J Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591 [TBL] [Abstract][Full Text] [Related]
5. A compound heterozygous ALPL variant in a patient with dystonia-parkinsonism and hypointensity in basal ganglia: A case report. Li XY; Wan XH; Chen L; Guo WH; Wang L Parkinsonism Relat Disord; 2020 Sep; 78():184-185. PubMed ID: 32956941 [No Abstract] [Full Text] [Related]
6. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327 [TBL] [Abstract][Full Text] [Related]
7. A novel FTL mutation responsible for neuroferritinopathy with asymmetric clinical features and brain anomalies. Moutton S; Fergelot P; Trocello JM; Plante-Bordeneuve V; Houcinat N; Wenisch E; Larue V; Brugières P; Clot F; Lacombe D; Arveiler B; Goizet C Parkinsonism Relat Disord; 2014 Aug; 20(8):935-7. PubMed ID: 24907184 [No Abstract] [Full Text] [Related]
8. Eye of the tiger sign in a 23 year patient with mitochondrial membrane protein associated neurodegeneration. Skowronska M; Kmiec T; Kurkowska-Jastrzębska I; Czlonkowska A J Neurol Sci; 2015 May; 352(1-2):110-1. PubMed ID: 25819119 [No Abstract] [Full Text] [Related]
9. Beta-propeller protein associated neurodegeneration (BPAN); the first report of three patients from Iran with de novo novel mutations. Rohani M; Fasano A; Akhoundi FH; Haeri G; Lang AE; Rahimi Bidgoli MM; Javanparast L; Zamani B; Shahidi G; Alavi A Parkinsonism Relat Disord; 2019 Apr; 61():231-233. PubMed ID: 30455156 [No Abstract] [Full Text] [Related]
10. Oculogyric crises in PLA2G6 associated neurodegeneration. Rohani M; Shahidi G; Vali F; Lang AE; Slow E; Gahl WA; Behnam B Parkinsonism Relat Disord; 2018 Jul; 52():111-112. PubMed ID: 29574084 [No Abstract] [Full Text] [Related]
11. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD). Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516 [TBL] [Abstract][Full Text] [Related]
12. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293 [TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms. Meyer E; Kurian MA; Hayflick SJ Annu Rev Genomics Hum Genet; 2015; 16():257-79. PubMed ID: 25973518 [TBL] [Abstract][Full Text] [Related]
14. Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria. Al Rawi S; Simpson L; Agnarsdóttir G; McDonald NQ; Chernuha V; Elpeleg O; Zeviani M; Barker RA; Spiegel R; Laman H FEBS J; 2024 Jun; 291(12):2565-2589. PubMed ID: 38466799 [TBL] [Abstract][Full Text] [Related]
16. [De novo mutations in the autophagy gene WDR45 cause SENDA/BPAN]. Muramatsu K No To Hattatsu; 2016 May; 48(3):177-83. PubMed ID: 27349079 [No Abstract] [Full Text] [Related]
17. Novel compound heterozygous FBXO7 mutations in a family with early onset Parkinson's disease. Lorenzo-Betancor O; Lin YH; Samii A; Jayadev S; Kim HM; Longfellow K; Distad BJ; Yearout D; Mata IF; Zabetian CP Parkinsonism Relat Disord; 2020 Nov; 80():142-147. PubMed ID: 33002721 [TBL] [Abstract][Full Text] [Related]
18. Juvenile-onset parkinsonism with pyramidal signs due to compound heterozygous mutations in the F-Box only protein 7 gene. Wei L; Ding L; Li H; Lin Y; Dai Y; Xu X; Dong Q; Lin Y; Long L Parkinsonism Relat Disord; 2018 Feb; 47():76-79. PubMed ID: 29174172 [TBL] [Abstract][Full Text] [Related]
19. F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy. Zhou ZD; Xie SP; Sathiyamoorthy S; Saw WT; Sing TY; Ng SH; Chua HP; Tang AM; Shaffra F; Li Z; Wang H; Ho PG; Lai MK; Angeles DC; Lim TM; Tan EK Hum Mol Genet; 2015 Nov; 24(22):6314-30. PubMed ID: 26310625 [TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration with brain iron accumulation disorder mimics autism. Veeravigrom M; Desudchit T; Chomtho K; Pongpunlert W Pediatr Neurol; 2014 Dec; 51(6):862-3. PubMed ID: 25456304 [No Abstract] [Full Text] [Related] [Next] [New Search]